Alterations in glycosylation as biomarkers for cancer detection

被引：354
|
作者：
Reis, Celso A. [1 ,2 ]
Osorio, Hugo [1 ]
Silva, Luisa [1 ]
Gomes, Catarina [1 ]
David, Leonor [1 ,2 ]
机构：
[1] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal
[2] Univ Porto, Fac Med, P-4100 Oporto, Portugal
来源：
JOURNAL OF CLINICAL PATHOLOGY | 2010年 / 63卷 / 04期
关键词：
POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; ALPHA-D-GALACTOSAMINE; SIALYL-TN ANTIGEN; ACETYL-D-GALACTOSAMINE; ADENOCARCINOMA CELL-LINES; O-LINKED GLYCOSYLATION; PRIMARY BREAST-CANCER; HUMAN-COLON-CANCER; LEWIS-X ANTIGEN; GASTRIC-CANCER;
D O I：
10.1136/jcp.2009.071035
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Glycoconjugates constitute a major class of biomolecules which include glycoproteins, glycosphingolipids and proteoglycans. Glycans are involved in several physiological and pathological conditions, such as host-epathogen interactions, cell differentiation, migration, tumour invasion and metastisation, cell trafficking and signalling. Cancer is associated with glycosylation alterations in glycoproteins and glycolipids. This review describes various aspects of protein glycosylation with the focus on alterations associated with human cancer. The application of these glycosylation modifications as biomarkers for cancer detection in tumour tissues and serological assays is summarised.
引用
收藏
页码：322 / 329
页数：8
相关论文
共 50 条
  • [31] Precursors of urinary bladder cancer: molecular alterations and biomarkers
    Taylor, Alexander S.
    Acosta, Andres M.
    Al-Ahmadie, Hikmat A.
    Mehra, Rohit
    HUMAN PATHOLOGY, 2023, 133 : 5 - 21
  • [32] Alterations in Breast Cancer Biomarkers Following Neoadjuvant Therapy
    Mohan, Srivarshini Cherukupalli
    Walcott-Sapp, Sarah
    Lee, Minna K.
    Srour, Marissa K.
    Kim, Sungjin
    Amersi, Farin F.
    Giuliano, Armando E.
    Chung, Alice P.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 5907 - 5917
  • [33] Unlocking the future of colorectal cancer detection: Advances in screening glycosylation-based biomarkers on biological mass spectrometry technology
    Li, Yuxuan
    Wang, Songze
    Han, Chengqiang
    Li, Xi-Ling
    Min, Jun Zhe
    JOURNAL OF CHROMATOGRAPHY A, 2024, 1738
  • [34] Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer
    Kang, Jeong-Gu
    Ko, Jeong-Heon
    Kim, Yong-Sam
    BMB REPORTS, 2011, 44 (12) : 765 - 771
  • [35] Advances in the discovery of novel biomarkers for cancer: spotlight on proteinN-glycosylation
    Zhang, Wenyao
    Yang, Zhiping
    Gao, Xiaoliang
    Wu, Qiong
    BIOMARKERS IN MEDICINE, 2020, 14 (11) : 1031 - 1046
  • [36] Detection of gastrointestinal cancer: the role of cancer biomarkers
    Caviglia, Gian Paolo
    MINERVA BIOTECNOLOGICA, 2019, 31 (01) : 1 - 2
  • [37] Glycosylation Changes as Non-Invasive Biomarkers for Lupus Nephritis Detection and Prognosis
    Angerstein, Aaron
    Drake, Richard
    Pasham, Vishwajeeth
    Wolf, Bethany
    Oates, Jim
    Nowling, Tammy
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3701 - 3702
  • [38] Detection of genetic alterations in human cancer
    Shimizu, K
    SEIKAGAKU, 1997, 69 (05): : 311 - 323
  • [39] GPNotebook: A toolkit for identifying cancer-related glycosylation alterations in glycoproteomic analysis
    Zhang, Hui
    Hoang, Trung
    Hu, Yingwei
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Early detection biomarkers for oesophageal cancer
    Fitzgerald, R.
    Fitzgerald, R. C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S14 - S14
12345